Abbes Seqqat currently serves as President of RAIN, the pioneering voice AI company behind "ORVA," the first-ever operating room voice assistant. With a rich background in driving innovation and business growth, Abbes has established himself as a visionary in the intersection of technology and healthcare.

Prior to his current role, Abbes held leadership positions at Sensetime, where he spearheaded business and growth initiatives across the Middle East and Africa (MEA) region. His strategic insights and leadership were instrumental in positioning Sensetime as a key player in the AI landscape, particularly within the medical imaging space.

Before his tenure at Sensetime, Abbes served as a trusted advisor on digital transformation and disruption to leading conglomerates in the region during his tenure at Oracle, IBM Watson Health and Accenture. His expertise in leveraging cutting-edge technologies has enabled organizations to revolutionize their operations and enhance patient care delivery.

His thought leadership and strategic guidance continue to shape the future of healthcare, driving innovation and improving outcomes for patients globally. With a proven track record of success and passion for leveraging technology for the greater good, Abbes remains at the forefront of the AI health tech industry, leading RAIN towards new heights of innovation and impact.

Dr Mohamed Alameri works at the Department of Health – Abu Dhabi (DoH) as Section Head of Studies and Special Projects. He has an impressive background in science, having received a Bachelors, Masters and a Doctorate focusing on genetics and cell and gene therapy. His current role is centred around genomic advancements within the DoH, including assisting within the incredible Emirati Genome Programme.

Dr Mohamed began his career as a Medical Laboratory Technologist at Sheikh Khalifa Medical City. There, he had a hands-on role, and gained a wealth of experience in the lab contributing to the diagnosis and treatment of patients. While finishing his PhD, Dr Mohamed worked as a part-time teacher for cell and gene therapy at University College London. Dr Mohamed is passionate about the possibilities of genomic sequencing, and how technology can be harnessed within the healthcare system to develop a dynamic genomic ecosystem and reshape the future of health.

Bunny Ellerin is a Harvard-trained healthcare entrepreneur and advisor who is highly sought-after
for her industry expertise and extensive network. She has helped build and sell companies, launched
several thriving networking organizations, and has become a recognized force in leading New York
City’s transformation into a thriving hub of healthcare innovation. An expert in digital health, Bunny
has herpulse on — and relationships to — the companies and people defining healthcare’s future.

Ivan is the founder and CEO of Kalibra.ai, a platform for personalised health optimisation. His unwavering passion for innovative approaches to extending human healthspan and improving whole-person health has been the driving force behind his career. Before embarking on his journey with Kalibra in 2021, Ivan dedicated 20 years to the financial services industry, serving as a research analyst, CEO, CFO, investor, and board member. For the past 14 years, he has been based in Singapore, where before starting Kalibra, he held the positions of Chief Investment Officer (Asia) and Portfolio Manager in multi-billion hedge funds.